|
|
Volumn 337, Issue 4, 1997, Pages 242-
|
|
Testicular germ-cell cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CHORIONIC GONADOTROPIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
ETOPOSIDE;
IFOSFAMIDE;
VINBLASTINE;
ADVANCED CANCER;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MEGADOSE;
GERM CELL TUMOR;
HISTOPATHOLOGY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NEUROTOXICITY;
NON SEMINOMATOUS GERMINOMA;
ORCHIECTOMY;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
SEMINOMA;
COMBINED MODALITY THERAPY;
GERMINOMA;
HUMANS;
MALE;
NEOPLASM STAGING;
TESTICULAR NEOPLASMS;
|
|
EID: 0030857028
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199707243370406 Document Type: Review |
|
Times cited : (781)
|
|
References (122)
|
